How long for losartan to lower bp
Pro Research Analysisby 
Searched over 200M research papers
How Long for Losartan to Lower Blood Pressure
Initial Blood Pressure Reduction with Losartan
Losartan, an angiotensin II receptor blocker, is commonly used to manage hypertension. The time it takes for losartan to lower blood pressure (BP) can vary based on several factors, including dosage and patient characteristics. Studies have shown that losartan can start to reduce blood pressure within a few weeks of initiation.
Short-Term Efficacy
In a study involving hypertensive children, losartan demonstrated a significant reduction in systolic blood pressure (SBP) and diastolic blood pressure (DBP) within 3 weeks of treatment initiation. The mean reductions in SBP were 7.3 mmHg, 7.6 mmHg, and 6.7 mmHg for low, medium, and high doses, respectively, while DBP reductions were 8.2 mmHg, 5.1 mmHg, and 6.7 mmHg2. This indicates that losartan can effectively lower BP within a short period, typically around 3 weeks.
Combination Therapies
When losartan is combined with other antihypertensive agents, the time to achieve significant BP reduction can be influenced by the additional medication. For instance, a study comparing losartan combined with amlodipine (a calcium channel blocker) versus losartan combined with hydrochlorothiazide (a diuretic) found that both combinations significantly reduced BP after 4 weeks of treatment1 4. The combination of losartan and amlodipine was particularly effective in reducing 24-hour ambulatory central BP, showing a more pronounced effect compared to the combination with hydrochlorothiazide4.
Long-Term Efficacy
Long-term studies have also demonstrated the sustained efficacy of losartan in lowering BP. In a study with hypertensive patients, losartan combined with hydrochlorothiazide showed significant BP reductions over a 6-month period, with target BP achieved in a high percentage of patients6. Another study with a 20-week follow-up period confirmed that losartan, whether combined with amlodipine or hydrochlorothiazide, maintained its BP-lowering effects throughout the treatment duration1 4.
Factors Influencing BP Reduction
Dosage and Titration
The dosage of losartan plays a crucial role in the extent and speed of BP reduction. In a dose-ranging study, patients who did not achieve their BP goals with initial dosages had their doses titrated up to a maximum of 1.4 mg/kg per day, which further enhanced BP control2. Similarly, in adult patients, increasing the dose of losartan from 50 mg to 100 mg when combined with other agents like amlodipine or hydrochlorothiazide resulted in more significant BP reductions1 4.
Patient Characteristics
Patient characteristics, such as the presence of comorbid conditions like obstructive sleep apnea (OSA), can also affect the BP-lowering efficacy of losartan. In patients with OSA, losartan alone reduced BP, but the addition of continuous positive airway pressure (CPAP) therapy further enhanced nighttime BP control5.
Conclusion
Losartan is effective in lowering blood pressure within a few weeks of initiation, with significant reductions observed as early as 3 weeks. The combination of losartan with other antihypertensive agents can enhance its efficacy, and dosage adjustments may be necessary for optimal BP control. Long-term studies confirm that losartan maintains its BP-lowering effects over extended periods, making it a reliable option for managing hypertension.
Sources and full results
Most relevant research papers on this topic
LOSARTAN/AMLODIPINE IN ARTERIAL STIFFNESS SHOWS DOMINANT EFFICACY IN REDUCING 24 HOURS BRACHIAL AND CENTRAL BP COMPARED WITH LOSARTAN/HYDROCHLOROTHIAZID OR IN NORMAL ARTERY
Losartan/amlodipine combination therapy is more effective in reducing 24 hours brachial and central blood pressure in patients with advanced arterial stiffness compared to losartan/hydrochlorothiazide or normal arterial patients.
RCTA randomized, open-label, dose-response study of losartan in hypertensive children.
Losartan at doses up to 1.4 mg/kg per day effectively reduces blood pressure in children aged 6 months to 6 years, with no dose-response relationship observed.
RCTEffectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension: results from the PREVER-treatment randomized trial
A combination of chlorthalidone and amiloride effectively lowers blood pressure compared to losartan in patients with stage I hypertension.
RCT
Large Human Trial
Very Rigorous JournalComparison of 24-Hour Ambulatory Central Blood Pressure Reduction Efficacy Between Fixed Amlodipine or Up-Titrated Hydrochlorothiazide Plus Losartan: The K-Central Study
The combination of losartan and amlodipine is more effective in reducing 24-hour ambulatory central blood pressure than the combination of losartan and hydrochlorothiazide, regardless of office systolic blood pressure.
RCTVery Rigorous JournalBlood Pressure Response to Losartan and Continuous Positive Airway Pressure in Hypertension and Obstructive Sleep Apnea.
Losartan reduces blood pressure in patients with obstructive sleep apnea, but the reductions are less than in no-osa patients, and add-on CPAP therapy shows no significant changes in 24-hour BP except in patients using CPAP efficiently.
RCT
Highly CitedComparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial
Losartan + HCTZ effectively lowers central systolic blood pressure and has a more positive impact on pulse wave velocity compared to bisoprolol + HCTZ in patients with moderate-to-severe hypertension.
RCT
Rigorous JournalLBOS 01-05 24-HOUR CENTRAL BLOOD PRESSURE REDUCTION EFFICACY OF CALCIUM CHANNEL BLOCKER COMBINATION IS SUPERIOR TO DIURETICS COMBINATION WITH ANGIOTENSIN II RECEPTOR BLOCKER ESPECIALLY IN MALE HYPERTENSIVE PATIENTS.
The combination of losartan and amlodipine effectively reduces 24-hour central blood pressure in men hypertensive patients compared to the combination of losartan and hydrochlorothiazide.
RCTVery Rigorous JournalDifferential effects of strict blood pressure lowering by losartan/hydrochlorothiazide combination therapy and high-dose amlodipine monotherapy on microalbuminuria: the ALPHABET study.
Losartan/hydrochlorothiazide combination therapy and high-dose amlodipine monotherapy both effectively lower blood pressure, but losartan/HCTZ has a greater impact on urinary albumin/creatinine ratio reduction.
RCTA randomized, comparative study evaluating the efficacy and tolerability of losartan-low dose chlorthalidone (6.25 mg) combination with losartan-hydrochlorothiazide (12.5 mg) combination in Indian patients with mild-to-moderate essential hypertension
The losartan/low-dose chlorthalidone (6.25 mg) combination is as effective as the widely used losartan/hydrochlorothiazide combination in lowering blood pressure and is well-tolerated for treating mild-to-moderate hypertension.
RCTA comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.
Candesartan cilexetil effectively reduces ambulatory blood pressure more effectively than losartan, with greater reductions observed even during the day of a missed dose.
RCTHighly Cited